Back
NEUROSAFE

Lava

Non-Adhesive Embolizing Liquid for the embolization of lesions in the neurovasculature and peripheral vasculature, including arteriovenous malformations (AVM) and hypervascularized tumors.

Details of the product

  • Composed of a co-polymer (EVOH) + DMSO + Tantalum Powder to facilitate its visibility during the procedure.
  • Kit components:
    • One 1,5mL vial of LAVA
    • One 1,5 mL vial of DMSO
    • A 1mL syringe for DMSO (blue)
    • Two 1 mL syringes for LAVA (white)
  • Non-adhesive, latest EVOH co-polymer technology.
  • Different degrees of viscosity (12cst, 18cst and 34cst), to adapt to different types of clinical treatment requirements.
  • Improved fluidity, deeper penetration into the nidus and microvasculature.
  • Release to achieve complete occlusion in a stable and controlled manner.
  • Excellent visibility thanks to a greater micronization of the size of the tantalum powder.

Technical Specifications

General characteristics
Composition: EVOH (Ethynyl-vinyl-Alcohol) + DMSO (solvent) + Tantalum
Available formats (According to EVOH Concentration) 4% EVOH, 6% EVOH and 8% EVOH
Available Viscosity 12cSt, 18cSt and 34cSt
Road volume 1,5ml
Recommended Microcatheter DMSO Compatible
Visibility Raised, micronized tantalum powder
Navigability Depending on EVOH concentration
Quick release Viscosity dependent depending on format

Order information

Order Information
References Description
LAVA-12 Non-adhesive embolizing agent EVOH + DMSO + Tantalum Conc. 4% and 12cSt
LAVA-18 Non-adhesive embolizing agent EVOH + DMSO + Tantalum Conc. 6% and 18cSt
LAVA-34 Non-adhesive embolizing agent EVOH + DMSO + Tantalum Conc. 8% and 34cSt